Specialist in Diabetes Complications Pharmacology

Novo Nordisk A/S

Ballerup, 1 stilling

- Research Scientist

- Denmark - Måløv





Do you have a passion for diabetes complications research and would you like to be part of a growing organization developing the next generation of medicines? We are looking to hire an experienced in vivo pharmacology specialist with expertise in diabetic nephropathy and/or retinopathy.



In Global Research we specialises in the discovery of biological medicines for the treatment of type 1 and 2 diabetes. We also discover and develop new innovative biopharmaceuticals for haemophilia and growth disorders. Furthermore, we conduct stem cell and beta cell regeneration research and other early-stage investigations aimed at finding a cure for diabetes, as well as exploring novel treatments for obesity and long-term, microvascular complications of diabetes.



Global Research consists of app. 1.500 highly qualified scientists, PhDs/post docs and lab technicians and we conduct our world class research from sites based in the Greater Copenhagen area, Beijing and Seattle.



We always strive for excellence and continuously develop our expertise to stay ahead - both as a company and as individuals. And we believe innovation and creativity thrive in a healthy and engaging working environment. Therefore, we give you the opportunity to bring your personal ambition and passion to work to improve the quality of life of our patients.



About the department

You will work in a department based in Måløv in the Greater Copenhagen area, Denmark, that supply pharmacology expertise for the development of new drug candidates within diabetic complications i.e. diabetic nephropathy and diabetic retinopathy in particular. The department consists of approximately 40 employees covering scientists, technicians, post docs and students divided into two teams that collaborate in an international and dynamic working environment with a good collaborative atmosphere. In the department, we have several established animal models and in vitro assays relevant for key mechanisms of diabetic complications and we constantly strive to implement state-of-the-art technology with the aim of delivering the highest possible quality of data for our research projects. The department is also closely involved in identification of novel project candidates and represents pharmacology in cross-functional project teams.



The job

You will employ your expert knowledge and your personal skills to lead the way for in vivo pharmacology in our diabetes complications projects. Through participation in cross-functional project groups and core teams you will be a key player in advancing the diabetes complications project portfolio. As study director you will oversee and guide state of the art in vivo research executing and optimizing existing models both internally and through our collaborators. You will also be developing, validating, and implementing new models to constantly push the state of the art. Finally, you will have a key role in the identification and evaluation of new drug targets both internally and through in-licensing opportunities.



Qualifications

You are a proven specialist (PhD level or beyond) within in vivo pharmacology and related disciplines, you are confident in collaborating as well as eventually leading others across professional fields. International experience within the field of diabetes complications research will be important as well as industrial experience and your passion for science, innovation and drug development is a must.



As a person you are ambitious, innovative, and dynamic with a positive attitude to new ideas and people; you use your excellent communication skills in everything you do and possess a strong quality mind-set.



At Novo Nordisk, your skills, dedication and ambition help us change lives for the better. In exchange, we offer you an opportunity to be part of a growing organisation with unique possibilities for personal and professional development, as well as a chance to work alongside the best in the field.



Contact

For further information, please contact Henrik Søndergaard at +45 3075 1376 or Claus Haase at +45 3075 9093.



Deadline

14 January 2016.